Stay updated with breaking news from Gel Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A mix of consumers looking to retain active lifestyles, and consumers’ prioritizing a proactive approach to maintaining joint health, are driving growth
Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Rating) was the recipient of a significant growth in short interest in March. As of March 31st, there was short interest totalling 65,600 shares, a growth of 75.4% from the March 15th total of 37,400 shares. Based on an average daily volume of 14,100 shares, the short-interest ratio is […]
HC Wainwright restated their buy rating on shares of Sol-Gel Technologies (NASDAQ:SLGL – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $19.00 price objective on the stock. HC Wainwright also issued estimates for Sol-Gel Technologies’ Q1 2024 earnings at ($0.21) EPS, Q2 2024 earnings at ($0.17) […]
BTIG cut the price target on Gain Therapeutics, Inc. (NASDAQ:GANX) from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the s...
NESS ZIONA, Israel, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying,...